Language selection

Search

2013-05-15 - Male - 49 Years old

526503

Adverse reaction report number 526503
Latest AER version number 0
Market authorization holder AER number ALL1201302834
Initial received date 2013-05-15
Latest received date 2013-05-15
Age 49 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Not recovered/not resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral20 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral20 Milligram2 every 1 Day(s) Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug effect decreased
Off label use
Overdose
Date modified: